We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-0.47%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$38.8B
AUM Growth
+$957M
Cap. Flow
+$1.75B
Cap. Flow %
4.52%
Top 10 Hldgs %
18.92%
Holding
4,122
New
310
Increased
2,005
Reduced
1,517
Closed
198

Sector Composition

Rank Sector Weight
1 Technology 11.12%
2 Financials 4.49%
3 Industrials 3.2%
4 Consumer Discretionary 3.13%
5 Communication Services 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUIZ
2126
Zacks Quality International ETF
QUIZ
$90.1M
$1.06M ﹤0.01%
+39,404
New +$1.1M
PCMM
2127
BondBloxx Private Credit CLO ETF
PCMM
$197M
$1.06M ﹤0.01%
21,527
-44
-0.2% -$2.2K
QLD icon
2128
ProShares Ultra QQQ
QLD
$14.3B
$1.06M ﹤0.01%
17,306
-35,783
-67% -$2.44M
CIFR icon
2129
Cipher Digital
CIFR
$7.45B
$1.05M ﹤0.01%
81,916
-11,826
-13% -$187K
ELF icon
2130
e.l.f. Beauty
ELF
$5.42B
$1.05M ﹤0.01%
17,390
-2,790
-14% -$227K
MITK icon
2131
Mitek Systems
MITK
$868M
$1.05M ﹤0.01%
+78,103
New +$966K
CGAU
2132
Centerra Gold
CGAU
$4.21B
$1.05M ﹤0.01%
59,249
-9,902
-14% -$176K
KOMP icon
2133
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.84B
$1.05M ﹤0.01%
17,977
+14,536
+422% +$909K
IGE icon
2134
iShares North American Natural Resources ETF
IGE
$793M
$1.05M ﹤0.01%
16,661
-35
-0.2% -$2.05K
PJP icon
2135
Invesco Pharmaceuticals ETF
PJP
$499M
$1.05M ﹤0.01%
10,109
+1,999
+25% +$211K
DJIA icon
2136
Global X Dow 30 Covered Call ETF
DJIA
$189M
$1.05M ﹤0.01%
49,801
+29,409
+144% +$647K
ECG
2137
Everus Construction Group
ECG
$7.18B
$1.05M ﹤0.01%
8,860
+1,345
+18% +$139K
SDVD icon
2138
FT Vest SMID Rising Dividend Achievers Target Income ETF
SDVD
$933M
$1.04M ﹤0.01%
48,148
-3,731
-7% -$83.8K
TKO icon
2139
TKO Group
TKO
$14.8B
$1.04M ﹤0.01%
5,184
-1,673
-24% -$342K
IVOG icon
2140
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.73B
$1.04M ﹤0.01%
8,343
+123
+1% +$15.7K
CRBU icon
2141
Caribou Biosciences
CRBU
$157M
$1.04M ﹤0.01%
547,014
-34,779
-6% -$59.7K
CORP icon
2142
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
$1.04M ﹤0.01%
10,728
+384
+4% +$37.6K
DWM icon
2143
WisdomTree International Equity Fund
DWM
$694M
$1.04M ﹤0.01%
14,822
-229
-2% -$16.4K
ACLS icon
2144
Axcelis
ACLS
$4.3B
$1.03M ﹤0.01%
11,100
-2,278
-17% -$202K
BDJ icon
2145
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.75B
$1.03M ﹤0.01%
119,344
-1,617
-1% -$15.1K
TOST icon
2146
Toast
TOST
$20.2B
$1.03M ﹤0.01%
38,829
+8,141
+27% +$243K
PNR icon
2147
Pentair
PNR
$10.5B
$1.03M ﹤0.01%
11,784
+10
+0.1% +$980
LDUR icon
2148
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.38B
$1.02M ﹤0.01%
10,685
+2,376
+29% +$228K
MOOD icon
2149
Relative Sentiment Tactical Allocation ETF
MOOD
$137M
$1.02M ﹤0.01%
24,961
+19,309
+342% +$802K
GH icon
2150
Guardant Health
GH
$21.2B
$1.02M ﹤0.01%
11,063
+218
+2% +$21.9K

Similar funds

Cambridge Investment Research Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Cambridge Investment Research Advisors held 4,122 positions worth $38.8B, up 2.5% from $37.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors deployed $1.75B of net new capital in Q1 2026, opening 310 new positions and adding to 2,005 existing holdings. Its largest new stake was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $35.4M trimmed.

  • Cambridge Investment Research Advisors's largest Q1 2026 buy was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.
  • Cambridge Investment Research Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $140M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $35.4M.
  • Cambridge Investment Research Advisors fully exited Nuveen S&P 500 Buy-Write Income Fund in Q1 2026, selling an estimated $7.82M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $38.8B portfolio in Q1 2026.
  • Cambridge Investment Research Advisors opened 310 new positions and closed 198 in Q1 2026.
  • Cambridge Investment Research Advisors's portfolio value rose 2.5% quarter-over-quarter to $38.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.